Clinical Efficacy of Cefixime for the Treatment of Early Syphilis
- PMID: 33640982
- PMCID: PMC8423500
- DOI: 10.1093/cid/ciab187
Clinical Efficacy of Cefixime for the Treatment of Early Syphilis
Abstract
Safe and efficacious alternative treatment options for syphilis are necessary. This randomized, 2-arm, noncomparative pilot study evaluated the efficacy of oral cefixime 400 mg in achieving a ≥4-fold rapid plasma reagin titer decrease by 3 or 6 months after treatment. The proportion of cefixime arm participants treated successfully was 87% (95% confidence interval, 69%-100%; 13/15). Clinical Trials Registration. NCT03752112.
Keywords: Treponema pallidum; cefixime; early syphilis; penicillin; syphilis.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
Similar articles
-
Phase II trial evaluating the clinical efficacy of cefixime for treatment of active syphilis in non-pregnant women in Brazil (CeBra).BMC Infect Dis. 2020 Jun 10;20(1):405. doi: 10.1186/s12879-020-04980-1. BMC Infect Dis. 2020. PMID: 32522244 Free PMC article.
-
Clinical trial protocol to evaluate the efficacy of cefixime in the treatment of early syphilis.Trials. 2020 Dec 9;21(1):1009. doi: 10.1186/s13063-020-04885-z. Trials. 2020. PMID: 33298143 Free PMC article.
-
A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis.Sex Transm Dis. 2002 Aug;29(8):486-90. doi: 10.1097/00007435-200208000-00010. Sex Transm Dis. 2002. PMID: 12172535 Clinical Trial.
-
Treatment of venereal diseases. II. Syphilis.Semin Drug Treat. 1972 Winter;2(3):289-93. Semin Drug Treat. 1972. PMID: 4617924 Review. No abstract available.
-
Syphilis.Clin Dermatol. 2004 Nov-Dec;22(6):461-8. doi: 10.1016/j.clindermatol.2004.07.009. Clin Dermatol. 2004. PMID: 15596316 Review.
Cited by
-
Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial.Lancet Infect Dis. 2024 Apr;24(4):404-416. doi: 10.1016/S1473-3099(23)00683-7. Epub 2024 Jan 8. Lancet Infect Dis. 2024. PMID: 38211601 Free PMC article. Clinical Trial.
-
Treatment of bacterial sexually transmitted infections in Europe: gonorrhoea, Mycoplasma genitalium, and syphilis.Lancet Reg Health Eur. 2023 Oct 26;34:100737. doi: 10.1016/j.lanepe.2023.100737. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37927440 Free PMC article. Review.
-
Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study.Lancet Microbe. 2023 Dec;4(12):e994-e1004. doi: 10.1016/S2666-5247(23)00219-7. Epub 2023 Oct 9. Lancet Microbe. 2023. PMID: 37827185 Free PMC article.
References
-
- World Health Organization. WHO guidelines for the treatment of Treponema pallidum (syphilis). Geneva, Switzerland: WHO, 2016. - PubMed
-
- Jarzebowski W, Caumes E, Dupin N, et al. ; FHDH-ANRS CO4 Study Team . Effect of early syphilis infection on plasma viral load and CD4 cell count in human immunodeficiency virus-infected men: results from the FHDH-ANRS CO4 cohort. Arch Intern Med 2012; 172:1237–43. - PubMed
-
- Centers for Disease Control and Prevention. Syphilis Surveillance Supplement 2013-2017 Centers for Disease Control and Prevention. 2019. Available at: https://www.cdc.gov/nchhstp/atlas/.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
